首页> 美国卫生研究院文献>Clinical Ophthalmology (Auckland N.Z.) >Intraocular pressure reduction using a fixed combination of timolol maleate 0.5 and brimonidine tartrate 0.2 administered three times daily

【2h】

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5 and brimonidine tartrate 0.2 administered three times daily

机译：每天3次使用固定的0.5％马来酸替莫洛尔和0.2％酒石酸溴莫尼定的固定眼压降低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundThe purpose of this study was to evaluate the safety and efficacy of a fixed combination of timolol maleate 0.5% + brimonidine tartrate 0.2% (Combigan®) for reduction for intraocular pressure (IOP) in patients with glaucoma when the dose frequency is increased from twice to three times daily.

机译：背景本研究的目的是评估将青光眼患者的剂量频率从2倍增加时，固定使用0.5％马来酸替莫洛尔+ 0.2％酒石酸溴莫尼定（Combigan®）固定的安全性和有效性，以降低青光眼患者的眼压（IOP）每天三遍

著录项

期刊名称 Clinical Ophthalmology (Auckland N.Z.)
作者
Elad Moisseiev; Shimon Kurtz; Moshe Lazar; Gabi Shemesh;
展开▼
作者单位

展开▼
年(卷),期 2013(7),-1
年度 2013
页码 1269–1273
总页数 5
原文格式 PDF
正文语种
中图分类眼科学;
关键词
Combigan® timolol brimonidine glaucoma dose frequency;

机译：Combigan®;噻吗洛尔;溴莫尼定;青光眼;剂量频率;

相似文献

外文文献
中文文献
专利

1. Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily [J] . Elad Moisseiev, Shimon Kurtz, Moshe Lazar, Clinical ophthalmology . 2013,第3期

机译：每天3次使用固定的0.5％马来酸替莫洛尔和0.2％酒石酸溴莫尼定的固定组合降低眼压
2. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. [J] . Hatanaka M, Grigera DE, Barbosa WL, Journal of glaucoma . 2008,第8期

机译：为期8周的多中心，随机，介入，开放标签，第4期，平行比较马来酸替莫洛尔0.5％/酒石酸溴莫尼定固定组合与马来酸替莫洛尔0.5％/多唑胺固定组合的疗效和耐受性2眼压升高的患者百分比。
3. Efficacy and tolerability of fixed combination of brimonidine 0.2%/timolol 0.5% compared with fixed combination of dorzolamide 2%/timolol 0.5% in the treatment of patients with elevated intraocular pressure: A meta-analysis of randomized controlled trials [J] . BudengeriP., ChengJ.-W., CaiJ.-P., Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics . 2013,第5期

机译：固定剂量溴莫尼定0.2％/噻吗洛尔0.5％与多佐胺2％/噻吗洛尔0.5％固定组合治疗高眼压的疗效和耐受性：一项随机对照试验的荟萃分析
4. Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevtion after Nd-YAG Laser Posterior Capsulolomy [C] . Cai Jiping, Wei Ruili, Ma xiaoye, Shanghai International Conference on Laser Medicine and Surgery . 2005

机译：预防性使用蒂莫尔马来酸，防止人工压力提升在ND-YAG激光后毛细血管后
5. Intraocular pressure reduction of fixed combination timolol maleate 0.5 and dorzolamide 2 (Cosopt) administered three times a day [O] . Gabi Shemesh, Elad Moisseiev, Moshe Lazar, 2012

机译：每天服用3次固定组合马来酸替莫洛尔0.5％和多佐胺2％（Cosopt）的眼压降低
6. Intraocular pressure reduction using a fixed combination of timolol maleate 0.5 and brimonidine tartrate 0.2 administered three times daily [O] . Elad Moisseiev 2013

机译：使用固定组合的氏炎马来酸盐0.5％和溴蒙丁酸酯0.2％每日施用三次

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5 and brimonidine tartrate 0.2 administered three times daily

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅